TFCI Gains Attention as JhunjhunwalaPartnered Fund Acquires Stake MD Shares Business Outlook Indias Renewable Energy Sector Faces Grid Integration Hurdles in Early 2026 Steel Stocks Rally as Government Extends Minimum Import Price on 66 Steel Products Bitcoin Retreats to 74500 Poised for Weekly Decline as Geopolitical Tensions Rise US April Payrolls Surge Beyond Expectations Yet Underlying Signals Raise Caution Jim Cramers Optimistic Intuit INTU Call Precedes Sharp Stock Decline IDT Q1 2026 Earnings Earnings Miss Estimates Despite Positive Stock Movement VLYPO Q1 2026 Earnings Preferred Stock Series B Reports EPS Beat Stock Edges Higher HAS Q1 2026 Earnings Strong EPS Beat Amid Mixed Market Response VRRM Q1 2026 Earnings EPS Beats Estimates on Strong Execution Stock Slightly Higher YALA Q1 2026 Earnings Positive EPS of 016 Drives Modest Share Uptick Marriott International Q1 2026 Earnings EPS Beats Estimates by 546 Shares Edge Lower Plains GP Holdings PAGP Edges Lower as Support Levels Come into Focus Ernexa Therapeutics Warrants ERNAW Surge 14 as Price Tests Key Resistance Level Solid Biosciences SLDB Rallies 37 as Stock Approaches Key Resistance at 720 Knowles Corporation KN Surges 387 as Stock Approaches Key Resistance Level Pagaya Technologies Warrants PGYWW Climb 1255 as LowPriced Warrants Test Key 006 Level Ooma Inc OOMA Edges Higher as Shares Hold Above Key Support Levels Quantum eMotion Corp QNC Surges 7 as Shares Break Above Key Support Level Arbutus Biopharma ABUS Dips 2 Testing Key Support Levels Amid Modest Trading Volume Calidi Biotherapeutics CLDI Slides 366 as Shares Test Support Levels Invesco Pennsylvania Value Municipal Income Trust VPV Edges Higher Testing Key Levels Pliant Therapeutics PLRX Holds Near Support Amid Modest Gains Key Levels in Focus Taiwan Stocks Surge as Weighted Index Gains 218 on Broad Market Rally USEG Q1 2026 Earnings EPS Falls Short of Estimates Amid Challenging Conditions MRNOW Warrants Under Pressure Shares Hover at 003 Amid Steep Decline Icahn Enterprises Q1 2026 Earnings Significant EPS Miss Amid Investment Volatility Akari Therapeutics Q1 2026 Earnings EPS Miss Amid No Revenue Stock Surges 515 MSGS Q1 2026 Earnings LargerThanExpected Loss as OffSeason Weighs on Results PHGE Q4 2025 Earnings Deep EPS Miss Overshadowed by 103 Stock Surge NBBK Q1 2026 Earnings EPS Misses Consensus by 285 as Stock Defies Expectations CCSI Q1 2026 Earnings Strong EPS Beat Amidst Cautious Outlook RILYN Q1 2024 Earnings Significant Loss Reported Revenue Not Disclosed